<DOC>
	<DOCNO>NCT01063595</DOCNO>
	<brief_summary>The primary objective study compare efficacy Octaplas LG Octaplas SD term recovery coagulation factor haemostatic parameter . The secondary objective study compare safety tolerability Octaplas LG Octaplas SD term haematological clinical chemistry parameter adverse event monitoring .</brief_summary>
	<brief_title>A Trial Investigate Relative Efficacy , Safety , Tolerability Octaplas LG Versus Octaplas SD</brief_title>
	<detailed_description />
	<criteria>Capable understand comply aspect protocol . Signed Informed Consent . Capable understanding plasmapheresis information sheet sign . Healthy male female volunteer , age 18 year old . Women must negative pregnancy test ( human chorionic gonadotropin [ HCG ] base assay ) . Women must sufficient method contraception ( eg , intrauterine device , oral contraception , etc ) . No clinically relevant abnormality medical history general physical examination . Standard health insurance . Pregnancy lactation . Tattoos within last 3 month . Subject treat therapeutically fresh frozen plasma , blood , plasmaderived product within last 6 month . Hypersensitivity blood product plasma protein . History angioedema . History coagulation bleed disorder know abnormality affect coagulation , fibrinolysis , platelet function . Any clinically significant abnormal laboratory value . IgA deficiency . Seropositivity hepatitis B surface antigen , hepatitis C virus , human immunodeficiency virus type 1 type 2 antibody . Symptoms clinically relevant illness within 3 week first trial day . History suspect drug alcohol abuse . Subjects currently participate another clinical study . Any investigational medicinal product administration within last 4 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Octaplas LG</keyword>
	<keyword>Octaplas SD</keyword>
</DOC>